CompletedPhase 2NCT02237365
A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis
Studying OBSOLETE: Tuberculous meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oxford University Clinical Research Unit, Vietnam
- Principal Investigator
- Guy Thwaites, MD, PhDOxford University of Clinical Research
- Intervention
- 81mg aspirin(drug)
- Enrollment
- 120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Collaborators
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02237365 on ClinicalTrials.govOther trials for OBSOLETE: Tuberculous meningitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05383742Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous MeningitisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT05590455Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisANRS, Emerging Infectious Diseases